Needham & Company Reiterates a 'Buy' on Cantel Medical (CMN); Continues To Top Expectations
Tweet Send to a FriendGet Alerts CMN Hot Sheet
Price: $34.76 --0%
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 31 | New: 11
Rating Summary:
2 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 17 | Down: 31 | New: 11
Trade CMN Now!
Needham & Company reiterates a 'Buy' on Cantel Medical (NYSE: CMN) price target of $28.00 (from $26.00).
Analyst, Dalton Chandler, said, "CMN continues to top our expectations on the strength of its acquisitions and cost controls. Byrne Medical, acquired in August of last year in the largest deal by dollar volume CMN has done, rerformed exceptionally well with revenue up 28% Y/Y. The cost control initiatives implemented by management over the last couple of years are beginning to pay off in expanding margins, particularly the gross margin, which is also helped by the efficiency of the acquisition integrations."
Needham raises FY12 EPS estimate from $1.10 to $1.15 and FY13 from $1.37 to $1.39.
For an analyst ratings summary and ratings history on Cantel Medical click here. For more ratings news on Cantel Medical click here.
Shares of Cantel Medical closed at $24.80 yesterday, with a 52 week range of $18.84-$32.78.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Dalton Chandler, said, "CMN continues to top our expectations on the strength of its acquisitions and cost controls. Byrne Medical, acquired in August of last year in the largest deal by dollar volume CMN has done, rerformed exceptionally well with revenue up 28% Y/Y. The cost control initiatives implemented by management over the last couple of years are beginning to pay off in expanding margins, particularly the gross margin, which is also helped by the efficiency of the acquisition integrations."
Needham raises FY12 EPS estimate from $1.10 to $1.15 and FY13 from $1.37 to $1.39.
For an analyst ratings summary and ratings history on Cantel Medical click here. For more ratings news on Cantel Medical click here.
Shares of Cantel Medical closed at $24.80 yesterday, with a 52 week range of $18.84-$32.78.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Goldman Sachs Upgrades Meritor (MTOR) to Buy
- Goldman Sachs Downgrades Thoratec (THOR) to Neutral
- Pier 1 Imports (PIR) Sets Sights on Growing Ecommerce
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Needham & Company
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
